Should I Buy CPB? CPB 2026 Analysis

Should You Buy Campbell's Co (CPB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

28.830

1 Day change

0.42%

52 Week Range

43.420

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient entry: today’s +5.46% spike has pushed CPB into a key resistance area (~28.37), where near-term upside is limited and pullback risk is elevated.
Fundamentals are currently trending down (FY2026/Q1 YoY declines in revenue, EPS, margins), while Wall Street has been cutting price targets and maintaining mostly neutral ratings.
Options positioning is mixed (OI put/call slightly >1), and near-term pattern-probability data tilts bearish over 1W–1M.
If already holding, this looks more like a “hold/trim into strength” zone than an add/buy zone ahead of the 2026-03-04 earnings catalyst.

Technical Analysis

Price/levels: CPB at 28.35 is pressing into R2 resistance (28.372) after a sharp one-day rally; this is typically where upside stalls unless follow-through volume arrives.
Momentum: MACD histogram is positive (0.183) but contracting → bullish momentum is fading rather than accelerating.
RSI (6): 45.47 (neutral) → no strong “oversold bounce” signal to justify chasing.
Moving averages: converging → trend is not clearly established; the stock is more range-bound than trending.
Key levels: Pivot 27.05 (near-term “must-hold” for bulls); resistance 27.87 then 28.37; support 26.23 then 25.72.
Quant/pattern skew: similar-candlestick analysis implies a 40% chance of -1.3% next day, -1.78% next week, and -8.93% next month → near-term bias leans downside after a pop.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Options Data

Bearish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment: Open-interest put/call at 1.06 suggests slightly more downside hedging than upside positioning (mildly bearish/defensive).
Flow today: Volume put/call at 0.78 is mildly bullish (more calls than puts on the day), consistent with today’s price pop.
Volatility: 30D IV 35.92 vs historical vol 23.05; IV percentile 86.8 → options are expensive, implying the market is pricing elevated move/risk (often around event windows or uncertainty).
Positioning/participation: Today’s volume (1,461) is below 5D/10D averages (~2.1k), so the move isn’t strongly confirmed by unusually heavy options activity.

Technical Summary

Sell

Buy

Positive Catalysts

- Dividend/support narrative: news highlights CPB at a record-high dividend yield, which can attract defensive/income buyers.
- Institutional tone: Hedge funds are reported as buying aggressively (buying amount up 10801.13% QoQ), which can provide a floor.
- Potential catalyst date: Earnings on 2026-03-04 (pre-market) could reset expectations if margins/volume trends surprise positively.

Neutral/Negative Catalysts

- Earnings risk: With the next report on 2026-03-04 (Est. EPS 0.56), any continued margin pressure or weak snacks trends could trigger a downside re-rate.
- Competitive backdrop: analysts flag rising competition, value-focused promotions, and private-label momentum; snacks remain a key concern.
- Technical setup: price is at/near a major resistance level after a one-day surge, with fading MACD momentum—chasing here has unfavorable near-term risk/reward.
- Street sentiment: multiple recent price-target cuts and mostly neutral-to-cautious ratings reinforce a capped-upside narrative.

Financial Performance

Latest quarter (FY2026/Q1): Revenue 2.677B (-3.43% YoY), Net Income 194M (-11.01% YoY), EPS 0.65 (-9.72% YoY).
Profitability: Gross margin 29.44% (down 4.54% YoY) → margin compression is a key headwind.
Growth takeaway: the latest quarter shows weakening top-line and bottom-line trends rather than accelerating growth, which makes buying after a sharp daily rally less attractive.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: predominantly neutral stances (Equal Weight/Hold/Sector Perform) with repeated price-target cuts into late 2025–Jan 2026.
Notable cuts: Morgan Stanley 30→28 (Equal Weight); Barclays 30→27 (Equal Weight); Stifel 34→30 (Hold); RBC 35→30 (Sector Perform); UBS 28→26 (Sell).
Bull case on the Street: some view CPB’s portfolio as aligned with consumer trends (select brands performing well) and defensive characteristics can support the stock.
Bear case on the Street: concern about snacks weakness/competition, promotions/private-label pressure, and margin headwinds; targets drifting toward/under the current price suggest limited upside.
Influential/political trading: No recent congress trading data available; insiders are described as neutral (no significant recent trend).

15 Analyst Rating

Wall Street analysts forecast CPB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CPB is 31.13 USD with a low forecast of 26 USD and a high forecast of 38 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

10 Hold

3 Sell

Hold

Current: 28.710

Low

Averages

31.13

High

Current: 28.710

Low

Averages

31.13

High

Morgan Stanley

Megan Alexander Clapp

Equal Weight

downgrade

$30 -> $28

AI Analysis

2026-01-16

Reason

Morgan Stanley

Megan Alexander Clapp

Price Target

$30 -> $28

AI Analysis

2026-01-16

downgrade

Equal Weight

Reason

Morgan Stanley analyst Megan Alexander Clapp lowered the firm's price target on Campbell's to $28 from $30 and keeps an Equal Weight rating on the shares. In "an already challenging backdrop" for U.S. food stocks, the firm sees rising competitive risk as value-focused pricing, promotions, and private label momentum reaccelerate into 2026, the analyst tells investors in a note on the group.

Barclays

Equal Weight

maintain

$30 -> $27

2026-01-16

Reason

Barclays

Price Target

$30 -> $27

2026-01-16

maintain

Equal Weight

Reason

Barclays lowered the firm's price target on Campbell's to $27 from $30 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the consumer staples group as part of a Q4 earnings preview. Barclays attributes the recent "enthusiasm" in the stock to "a flight to safety" and remains concerned about company- and sector-level fundamentals. Potential oil and currency headwinds could materialize in 2026, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CPB

Unlock Now

CPB Should I Buy

CPB Should I Buy

Should You Buy Campbell's Co (CPB) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch